Skip to main content
AAPL-0.23%NVDA-1.01%MSFT-0.39%GOOGL-0.98%AMZN-0.83%TSM-1.67%SPCX-0.59%AVGO-4.76%META-0.69%TSLA-0.77%LLY+1.14%BRK-B+0.53%WMT+1.51%SKHY-4.30%JPM+0.98%MU-2.04%AMD-8.75%V+1.30%XOM+0.48%JNJ+0.79%MA+1.32%ASMLa-2.76%ABBV+0.20%COST+1.28%1398.HK+1.02%0700.HK-3.06%CVX+1.64%KO+1.86%PG+1.05%ORCL-1.38%CSCO-6.24%UNH+0.58%0939.HK+0.57%BAC+1.01%HD+0.12%GE+0.29%3988.HK+0.64%0857.HK+2.79%1816.HK+0.65%INTC-2.52%PM+1.17%1288.HK+1.18%0005.HK-0.57%HSBA.L+0.03%NVS+0.16%MS+0.78%AMAT-2.74%AZN+0.04%AP2d-8.10%LRCX-3.36%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%NZDMXN0.00%GBPSGD0.00%EURNOK0.00%GBPCHF0.00%PLNJPY0.00%CHFNOK0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%CADJPY0.00%EURSEK0.00%GBPUSD0.00%CHFJPY0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPAUD0.00%GBPNZD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURDKK0.00%NZDJPY0.00%EURPLN0.00%EURCAD0.00%EURUSD0.00%EURJPY0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.42%ETHUSD+62.73%USDTUSD+0.03%XRPUSD+64.19%SOLUSD+68.57%TRXUSDT-0.43%ZECUSDT+4.75%DOGEUSD+63.45%XMRUSDT+5.20%LINKUSD+4.17%XLMUSD+3.42%BCHUSDT+3.68%LTCUSD+50.45%UNIUSD+5.48%SUIUSD+4.13%TONUSD+64.57%HBARUSDT+4.79%TAOUSDT+4.87%AAVEUSD+8.62%ICPUSDT+2.08%DOTUSDT+3.56%ONDOUSDT+3.90%JUPUSDT+7.34%ARBUSDT+4.90%WLDUSDT+5.00%INJUSDT+2.38%ATOMUSDT+3.47%STXUSDT+1.83%PYTHUSDT+2.38%TIAUSDT+3.41%FETUSDT+3.24%SEIUSDT+5.01%IMXUSDT+1.68%GRTUSDT+3.75%OPUSDT+2.16%POLUSDT+2.52%WIFUSDT+3.28%IOTAUSDT+1.21%AXSUSDT+2.25%EOSUSDT+7.04%FARTCOINUSDT+4.99%DYDXUSDT+2.45%GALAUSDT+3.45%ORDIUSDT+3.87%NOTUSDT+1.53%RONINUSDT+0.94%AAPL-0.23%NVDA-1.01%MSFT-0.39%GOOGL-0.98%AMZN-0.83%TSM-1.67%SPCX-0.59%AVGO-4.76%META-0.69%TSLA-0.77%LLY+1.14%BRK-B+0.53%WMT+1.51%SKHY-4.30%JPM+0.98%MU-2.04%AMD-8.75%V+1.30%XOM+0.48%JNJ+0.79%MA+1.32%ASMLa-2.76%ABBV+0.20%COST+1.28%1398.HK+1.02%0700.HK-3.06%CVX+1.64%KO+1.86%PG+1.05%ORCL-1.38%CSCO-6.24%UNH+0.58%0939.HK+0.57%BAC+1.01%HD+0.12%GE+0.29%3988.HK+0.64%0857.HK+2.79%1816.HK+0.65%INTC-2.52%PM+1.17%1288.HK+1.18%0005.HK-0.57%HSBA.L+0.03%NVS+0.16%MS+0.78%AMAT-2.74%AZN+0.04%AP2d-8.10%LRCX-3.36%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%NZDMXN0.00%GBPSGD0.00%EURNOK0.00%GBPCHF0.00%PLNJPY0.00%CHFNOK0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%CADJPY0.00%EURSEK0.00%GBPUSD0.00%CHFJPY0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPAUD0.00%GBPNZD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURDKK0.00%NZDJPY0.00%EURPLN0.00%EURCAD0.00%EURUSD0.00%EURJPY0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.42%ETHUSD+62.73%USDTUSD+0.03%XRPUSD+64.19%SOLUSD+68.57%TRXUSDT-0.43%ZECUSDT+4.75%DOGEUSD+63.45%XMRUSDT+5.20%LINKUSD+4.17%XLMUSD+3.42%BCHUSDT+3.68%LTCUSD+50.45%UNIUSD+5.48%SUIUSD+4.13%TONUSD+64.57%HBARUSDT+4.79%TAOUSDT+4.87%AAVEUSD+8.62%ICPUSDT+2.08%DOTUSDT+3.56%ONDOUSDT+3.90%JUPUSDT+7.34%ARBUSDT+4.90%WLDUSDT+5.00%INJUSDT+2.38%ATOMUSDT+3.47%STXUSDT+1.83%PYTHUSDT+2.38%TIAUSDT+3.41%FETUSDT+3.24%SEIUSDT+5.01%IMXUSDT+1.68%GRTUSDT+3.75%OPUSDT+2.16%POLUSDT+2.52%WIFUSDT+3.28%IOTAUSDT+1.21%AXSUSDT+2.25%EOSUSDT+7.04%FARTCOINUSDT+4.99%DYDXUSDT+2.45%GALAUSDT+3.45%ORDIUSDT+3.87%NOTUSDT+1.53%RONINUSDT+0.94%
IL

IDEXX Laboratories, Inc. (IDXX)

NASDAQ • Healthcare

$704.23
+$6.21 (+0.9%)
Market closed

November 13, 2026 at 21:00 UTC

Open$710.24
Day Range$702.53 - $711.23
Avg. Volume (3M)684.6K
Market Cap$55.4B
P/E Ratio47.5
52 Week Range
$500.61$769.98
Next EarningsIn 78 daysFeb 1, 2027

Interactive Chart

22:08:29 UTC

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$1.2B100%
Gross Profitminus cost of goods$764.2M63%
Operating Incomeminus R&D and overhead$402.3M33%
Net Incomeminus taxes and the rest$317.1M26%

In plain terms: out of every $100 in revenue, IDEXX Laboratories, Inc. keeps $26 as net profit.

Fundamentals & Financials

Revenue (TTM)
$4.6B
Net Income (TTM)
$1.1B
EPS (TTM)
$14.83
ROA (TTM)
31.89%
Current Ratio
1.19

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+1.8%Q2 2026$3.47
+8.4%Q3 2026$4.27
+6.2%Q4 2026$3.96
Next

Feb 1

in 78 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +6.2%

IDEXX Laboratories beat expectations on both the top and bottom line in the third fiscal quarter of 2026, reported November 2, 2026, with EPS of $3.96 topping the $3.73 estimate (+6.2%) and revenue of $1.214 billion topping the $1.192 billion estimate (+1.9%). Revenue rose ~10% to about $1.2 billion (up from $1.105 billion a year ago), supported by the company’s diagnostic and information offerings across its companion animal, livestock and dairy, biomedical research, and water testing lines. Profitability remained elevated, with gross margin near 63% and operating margin around 33%, as gross profit reached roughly $764 million and operating income was about $402 million. Net income increased ~16% to roughly $317 million (up from $274.6 million a year ago), alongside EPS up from $3.40 a year ago. IDEXX generated about $450 million of operating cash flow during the quarter and repurchased roughly $112 million of stock. For the next period, consensus calls for EPS of $3.37 on revenue of $1.179 billion.

View full earnings history

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. (NASDAQ: IDXX) develops diagnostic and information products for animal health and water testing within the medical diagnostics and research business, generating $4.3 billion in FY2025 revenue. Its work spans veterinary care, livestock and dairy monitoring, biomedical research support, and microbiological testing tools used in water quality programs worldwide.

Name
IDEXX Laboratories, Inc.
CEO
Michael Erickson
Industry
Healthcare
Year Founded
1983
Employees
11,000

Today's Snapshot

AI-generated

IDXX closed 0.9% higher at 704.23, in line with a firmer sector. Trading was lighter than usual, with volume about half of its usual level.

Trading Volume

Below 10d avg (849.8K)

392.3K

vs S&P 500 Today

Outperforming Market

+1.25%

Updated: November 13, 2026 at 21:25 UTC

Technical Indicators

6 Buy0 Neutral2 Sell
IDXX is priced near $704 and combines robust trend and momentum with short-term overbought signals. The stock sits comfortably above its key moving averages, ADX above 35 confirms a strong trend, and MACD and momentum are strongly positive with OBV supportive of the advance. At the same time, RSI and stochastic readings are in overbought territory, suggesting short-term exhaustion risk, and volatility is moderate with an ATR near $24. Technical takeaway: Strong Buy — underlying trend and volume are constructive despite short-term overbought conditions.
All signals
  • EMA (5 indicators)$576.41 - $676.81
    Buy
  • RSI (14)71.56
    Sell
  • Stochastic %K (14, 3, 3)93.00
    Sell
  • MACD Level (12, 26)44.00
    Buy
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.